Syed Ali-aamir Rizvi
CIK 1897621 · Chief Medical Officer · last filed 2026-02-13
Syed Ali-aamir Rizvi is a Chief Medical Officer who has filed 7 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for RCKTW, was dated Feb 13, 2026. Across all open-market trades the lifetime net is −$35.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $98.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$98.7K
3
7
-$35.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCKTW | Chief Medical Officer | 407,874 | $0.01 | $4.0K | $0 | 2 | 2026-02-13 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Chief Medical Officer | 0 | $9.50 | $0 | $0 | 2 | 2025-01-08 |
| CRBU | Chief Medical Officer | 59,373 | $1.59 | $94.7K | -$35.5K | 3 | 2023-02-23 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-13 | RCKTW | Grant (A) | +61,963 | $0 | EDGAR |
| 2025-10-08 | RCKTW | Grant (A) | +345,911 | $0 | EDGAR |
| 2025-01-08 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | −185,000 | $0 | EDGAR |
| 2024-04-03 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +185,000 | $0 | EDGAR |
| 2023-02-23 | CRBU | Grant (A) | — | $0 | EDGAR |
| 2023-01-20 | CRBU | Sell (S) | −5,627 | -$35.5K | EDGAR |
| 2022-01-25 | CRBU | Grant (A) | +60,000 | $0 | EDGAR |